Partnering to build integrated oncology solutions

A comprehensive approach

Philips recognizes that oncology care requires integrated approaches across patient pathways. From diagnosis and staging, to treatment decision, to therapy planning and follow-up, Philips is addressing challenges in cancer care by providing solutions across the entire care delivery pathway.

Want to connect with a sales rep?

Complete the form and someone will get back to you.

Oncology portfolio segments

  • Disease Management Solutions

    Disease Management Solutions

    See our portfolio
  • Oncology Informatics

    Oncology Informatics

    Discover Philips oncology informatics with AI to unite radiology, oncology and genomics for to assist with precision diagnosis and personalized cancer care pathways.

    See our portfolio
  • Digital Pathology

    Digital Pathology

    Meet the challenges of today’s busy pathology lab with a digital pathology solution that helps to increase workflow efficiencies, speed up consults and uncover new insights. Find out more here.

    See our portfolio
  • Radiation Oncology

    Radiation Oncology

    Philips offers a proven portfolio of dedicated radiotherapy solutions that span diagnostic imaging to treatment planning. Discover more here.

    See our portfolio
finding doris

Bringing Radiology and Urology together like never before

Philips comprehensive prostate care solution extends the power of MRI beyond Radiology to help add clinical efficiency and enhanced collaboration across the care pathway. DynaCAD Prostate’s advanced post-processing and automated PI-RADS® reporting provides the critical diagnostics information for a fusion targeted biopsy with UroNav using real-time ultrasound guidance.

robert banner image

Encompass the expertise of Dana-Farber Cancer Institute through Philips Oncology Pathways

Philips Oncology Pathways, powered by Dana-Farber Cancer Institute, delivers high-quality, evidence-based treatment paths and can serve as an important tool in improving care quality and reducing costs. Based on the captured patient information, the clinical user is able to navigate through the branches of the pathways to make clinical decisions and provide a treatment plan recommendation including clinical trials.

crystals banner image

Empowering Pathologists with Digital & Computational Pathology

Philips Digital & Computational Pathology aims to reduce the pressure on pathologists by streamlining workflow, sharpening diagnostic processes, facilitating partnership, and enabling collaboration regardless of location. Enhancing the patient experience and supporting personalized treatment options, the Digital & Computational Pathology Solutions works to bring precision medicine to your clinical practice.

north america

Philips Radiation Oncology Solutions: the confident path to treatment

Philips offers a proven portfolio of dedicated radiotherapy solutions that span diagnostic imaging to treatment planning. By integrating tools, systems, and software, we help you to improve patient care, accelerate time to treatment, enhance patient satisfaction, while maximizing the value of your investment.

PI-RADS® is a registered trademark of The American College of Radiology.

*

Contact information

* This field is mandatory

*
*
*
*
*
*
*
*
*

By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.

*
*

Final CEE consent

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.